Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient.
Schaffrin-Nabe D, Josten-Nabe A, Tannapfel A, Uhl W, Garmer M, Kurzrock R, Crook T, Limaye S, Schuster S, Patil D, Schaffrin M, Mokbel K, Voigtmann R. Schaffrin-Nabe D, et al. Among authors: patil d. Front Oncol. 2024 May 3;14:1395618. doi: 10.3389/fonc.2024.1395618. eCollection 2024. Front Oncol. 2024. PMID: 38764581 Free PMC article.
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial.
Nagarkar R, Patil D, Crook T, Datta V, Bhalerao S, Dhande S, Palwe V, Roy S, Pandit P, Ghaisas A, Page R, Kathuria H, Srinivasan A, Akolkar D. Nagarkar R, et al. Among authors: patil d. Oncotarget. 2019 Sep 24;10(54):5605-5621. doi: 10.18632/oncotarget.27188. eCollection 2019 Sep 24. Oncotarget. 2019. PMID: 31608137 Free PMC article.
Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer.
Akolkar D, Patil D, Crook T, Limaye S, Page R, Datta V, Patil R, Sims C, Ranade A, Fulmali P, Fulmali P, Srivastava N, Devhare P, Apurwa S, Patel S, Patil S, Adhav A, Pawar S, Ainwale A, Chougule R, Apastamb M, Srinivasan A, Datar R. Akolkar D, et al. Among authors: patil d, patil s, patil r. Int J Cancer. 2020 Jun 15;146(12):3485-3494. doi: 10.1002/ijc.32815. Epub 2019 Dec 16. Int J Cancer. 2020. PMID: 31785151 Free PMC article.
Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Nagarkar R, Patil D, Limaye S, Devhare P, Ghaisas A, Srivastava N, Apurwa S, Patil S, John J, Raazi Z, Shreenivas A, Sambath J, Srinivasan A, Kumar P, Akolkar D, Datar R. Nagarkar R, et al. Among authors: patil d, patil s. Oncotarget. 2020 Nov 10;11(45):4195-4200. doi: 10.18632/oncotarget.27793. eCollection 2020 Nov 10. Oncotarget. 2020. PMID: 33227091 Free PMC article.
Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers.
Page R, Patil D, Akolkar D, Murthy SS, Bendale K, Patil R, Fulmali P, Fulmali P, Adhav A, Puranik S, Apurwa S, Datta V, Bose C, Schuster S, John J, Srinivasan A, Datar R. Page R, et al. Among authors: patil d, patil r. PLoS One. 2022 Jun 17;17(6):e0270139. doi: 10.1371/journal.pone.0270139. eCollection 2022. PLoS One. 2022. PMID: 35714131 Free PMC article.
917 results